Skip to main content

RSC Chemical Tools Meeting, October 1st 2009, Stevenage, Herts

Here is a link for a Royal Society of Chemistry (RSC) meeting held in Stevenage in October.

The schedule is....

10.00 Herbert Waldmann MPI of Molecular Physiology, Dortmund, Germany
Bioactivity Guided Navigation of Chemical Space

10.40 John Overington European Bioinformatics Institute, Hinxton, UK
ChEMBL - Open Access Databases and Tools for Drug Discovery

11.20 Malcolm Young University of Newcastle, UK
Counterintuitive properties of complex networks in brains and cells

12.00 Lunch

13.00 Chris Schofield University of Oxford, UK
The Hypoxic Response - from Molecules to Systems

13:40 Albert Heck University of Utrecht, The Netherlands
Chemical Proteomics: Exploring the Role of Small Molecules in Molecular Systems Biology

14.40 Seth Grant MRC Cambridge, UK
Synapse Systems Biology: New Models of Brain Organisation

15.20 Glenn Prestwich University of Utah, Salt Lake City, USA
Engineered Extracellular Matrices for Drug Discovery and Reparative Medicine

16.00 Round Table Discussion

17:00 Close

The picture above is of Stevenage town center, I have never seen the sky so blue there (I live nearby), maybe it is photoshopped?


Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site: Please see ChEMBL_34 release notes for full details of all changes in this release: New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the